Compare EVTL & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVTL | SOPH |
|---|---|---|
| Founded | 2016 | 2011 |
| Country | United Kingdom | Switzerland |
| Employees | 454 | N/A |
| Industry | Aerospace | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 338.7M | 367.7M |
| IPO Year | N/A | 2021 |
| Metric | EVTL | SOPH |
|---|---|---|
| Price | $2.40 | $4.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $12.70 | $7.50 |
| AVG Volume (30 Days) | ★ 5.0M | 89.3K |
| Earning Date | 03-24-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $23.09 |
| Revenue Next Year | N/A | $19.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.90 | $2.59 |
| 52 Week High | $7.60 | $5.70 |
| Indicator | EVTL | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 40.54 | 45.78 |
| Support Level | $1.90 | $4.55 |
| Resistance Level | $4.70 | $4.86 |
| Average True Range (ATR) | 0.27 | 0.25 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 12.60 | 30.67 |
Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero-emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.